Medical Marijuana is a New Trend for International Investors — Understand the Phenomenon
From rags to riches, pot producers are enjoying a higher demand in territories where prohibition is left behind.
In contrast with previous decades, conservative views have won and lost crucial battles, you can prove this in various fields of modern society: Government policy, gay marriage, economy, welfare, and others. The legalization of marijuana in many countries comes as a surprise for detractors and as an historical achievement for supporters/consumers.
Companies see the space as a vast market waiting to be filled with new products, options and tastes around the pot business, some have failed along the way and others have found promising paths to success, so much that 3 names have been listed on the Nasdaq recently: Cronos Group (CRON) pioneer at the stock exchange, Canopy Growth Corp (CGC) and now Tilray (TLRY) taking advantage of the momentum with the possible legalization in Canadian territory.
The case of Tilray’s IPO in this quarter comes 5 years after its foundation in 2013, subsidiary of Privateer Holdings, an investment firm focused on cannabis growth. Now, is supplying markets from all over the globe like: Latin America, Canada, Europe, Africa, Australia and New Zealand.
See also:
Offering 9 million shares at a price range of $14–16, this event becomes a clear sign of a worldwide phenomenon with new promising markets in Germany, scientific discoveries about the positive effects of medical marijuana against depression, record-breaking numbers in return on investment and roads opening ahead; the pot business seems strong enough to last longer than expected.
International Investor is an online magazine that provides insights, news and visual informative pieces with topics ranging from world markets, investing opportunities, industry analysis and so much more. All content is dedicated to the global investment community that wants to take a step ahead.
